Very briefly, for generics, the whole idea here is to have affordable drugs for Canadians. You mentioned that if we looked at this a little differently, the costs for Canadians would go down. Yet if we look at the OECD averages, I think generic drugs in Canada are the highest amongst all countries. Is that true? And along the same argument, with IP protection, why don't they go down further?
On May 8th, 2008. See this statement in context.